Luo Gang, Gao Feng, Zhang Xuelei, Jia Baixue, Huo Xiaochuan, Liu Raynald, Chi Man Sum, Ma Gaoting, Peng Guangge, Zhang Jingyu, Qi Zhongqi, Guo Xu, Han Bin, Tong Xu, Wang Bo, Song Ligang, Liu Lian, He Zijun, Mo Dapeng, Ma Ning, Sun Xuan, Yang Ming, Miao Zhongrong
Interventional Neuroradiology Center, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
China National Clinical Research Center for Neurological Diseases, Beijing, China.
Front Neurol. 2021 Sep 30;12:739213. doi: 10.3389/fneur.2021.739213. eCollection 2021.
Studies on rescue therapy for acute posterior circulation stroke due to basilar artery occlusion (BAO) are limited in the modern era of mechanical thrombectomy (MT). The aim of this study was to evaluate the safety and efficacy of rescue stenting (RS) following MT failure in patients with BAO. Data were collected from the Endovascular Treatment Key Technique and Emergency Work Flow Improvement of Acute Ischemic Stroke (ANGEL-ACT) prospective registry in China. Patients who underwent MT for BAO with failure of recanalization were enrolled in this study. The patients were divided into the RS and non-RS groups. Clinical and laboratory findings, procedural details, and clinical outcomes were compared between the two groups. Overall, 93 patients with acute BAO were analyzed. The RS group included 81 (87.1%) patients, and the non-RS group included 12 patients. A modified treatment in cerebral infarction (mTICI) score of 2b/3 was achieved in 75 (92.6%) patients in the RS group. Compared with the non-RS group, the RS group had a significantly higher rate of successful recanalization and favorable clinical outcomes (modified Rankin Scale score at 90 days post-procedure, 0-3: 16.7 vs. 51.9%, respectively; = 0.023) without an increase in the rate of symptomatic intracranial hemorrhage and a significantly lower mortality rate (58.3 vs. 18.5%, respectively; = 0.006). Furthermore, the use of a glycoprotein IIb/IIIa inhibitor improved the rate of recanalization of the target artery without increasing the rate of symptomatic intracranial hemorrhage. Permanent stenting appears to be a feasible rescue modality when MT fails and might provide functional benefits in patients with acute ischemic stroke due to BAO.
在机械取栓(MT)的现代时代,关于基底动脉闭塞(BAO)所致急性后循环卒中的挽救治疗研究有限。本研究的目的是评估BAO患者MT失败后挽救性支架置入术(RS)的安全性和有效性。数据来自中国急性缺血性卒中血管内治疗关键技术与急诊工作流程改进(ANGEL-ACT)前瞻性登记研究。因BAO接受MT但再通失败的患者纳入本研究。患者分为RS组和非RS组。比较两组的临床和实验室检查结果、手术细节及临床结局。总体而言,对93例急性BAO患者进行了分析。RS组包括81例(87.1%)患者,非RS组包括12例患者。RS组75例(92.6%)患者实现了改良脑梗死治疗(mTICI)2b/3级评分。与非RS组相比,RS组成功再通率和良好临床结局率显著更高(术后90天改良Rankin量表评分0 - 3级:分别为16.7% vs. 51.9%;P = 0.023),且症状性颅内出血发生率未增加,死亡率显著更低(分别为58.3% vs. 18.5%;P = 0.006)。此外,使用糖蛋白IIb/IIIa抑制剂可提高靶血管再通率,且不增加症状性颅内出血发生率。当MT失败时,永久性支架置入术似乎是一种可行的挽救方式,可能为BAO所致急性缺血性卒中患者带来功能益处。